Redhill Biopharma Stock Price on September 19, 2024
| RDHL Stock | USD 6.78 0.04 0.59% |
If you're considering investing in Redhill Stock, it is important to understand the factors that can impact its price. As of today, the current price of Redhill Biopharma stands at 6.78, as last reported on the 25th of November, with the highest price reaching 6.95 and the lowest price hitting 6.75 during the day. Redhill Biopharma maintains Sharpe Ratio (i.e., Efficiency) of -0.0149, which implies the firm had a -0.0149% return per unit of risk over the last 3 months. Redhill Biopharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Redhill Biopharma's Coefficient Of Variation of (6,727), insignificant risk adjusted performance, and Variance of 21.18 to confirm the risk estimate we provide.
Redhill Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Redhill |
Sharpe Ratio = -0.0149
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RDHL |
Estimated Market Risk
| 4.6 actual daily | 40 60% of assets are more volatile |
Expected Return
| -0.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Redhill Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Redhill Biopharma by adding Redhill Biopharma to a well-diversified portfolio.
Related Headline
Evoke Pharma Headline on 19th of September 2024
Acquisition by Donofrio Matthew J of 150000 shares of Evoke ... by globenewswire.com
Filed transaction by Evoke Pharma Officer: Exec Vp, Chief Bus. Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Redhill Biopharma Valuation on September 19, 2024
It is possible to determine the worth of Redhill Biopharma on a given historical date. On September 19, 2024 Redhill was worth 9.75 at the beginning of the trading date compared to the closed value of 9.68. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Redhill Biopharma stock. Still, in general, we apply an absolute valuation method to find Redhill Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Redhill Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Redhill Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 10.15 | 10.25 | 9.75 | 9.75 | 32,670 | |
09/19/2024 | 9.75 | 9.98 | 9.63 | 9.68 | 19,886 |
| 9.70 | 11.07 | 9.50 | 9.50 | 14,956 |
| Backtest Redhill Biopharma | | | Redhill Biopharma History | | | Redhill Biopharma Valuation | Previous | Next |
Redhill Biopharma Trading Date Momentum on September 19, 2024
| On September 20 2024 Redhill Biopharma was traded for 9.50 at the closing time. The top price for the day was 11.07 and the lowest listed price was 9.50 . The trading volume for the day was 15 K. The trading history from September 20, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.86% . The trading delta at closing time against the current closing price is 10.85% . |
Redhill Biopharma Fundamentals Correlations and Trends
By evaluating Redhill Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Redhill Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Redhill financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Redhill Biopharma Stock history
Redhill Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Redhill is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Redhill Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Redhill Biopharma stock prices may prove useful in developing a viable investing in Redhill Biopharma
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel. Redhill Biophrma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 201 people.
Redhill Biopharma Stock Technical Analysis
Redhill Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Redhill Biopharma Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Redhill Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Redhill Biopharma November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Redhill Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Redhill Biopharma shares will generate the highest return on investment. By undertsting and applying Redhill Biopharma stock market strength indicators, traders can identify Redhill Biopharma entry and exit signals to maximize returns
Redhill Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Redhill Biopharma's price direction in advance. Along with the technical and fundamental analysis of Redhill Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Redhill to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.80) | |||
| Treynor Ratio | 0.2295 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Redhill Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more information on how to buy Redhill Stock please use our How to buy in Redhill Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Redhill Biopharma. If investors know Redhill will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Redhill Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Redhill Biopharma is measured differently than its book value, which is the value of Redhill that is recorded on the company's balance sheet. Investors also form their own opinion of Redhill Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Redhill Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Redhill Biopharma's market value can be influenced by many factors that don't directly affect Redhill Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Redhill Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Redhill Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Redhill Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.